Antithrombotic coating material as well as preparation method and application thereof
By forming an antithrombotic coating containing polyphenol polymers, metal ions, and thrombin inhibitors on vascular stents, the problems of thrombosis and restenosis after vascular stent implantation are solved, achieving a highly efficient antithrombotic protective effect.
Patent Information
- Application Number
- CN202411101923.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-19
AI Technical Summary
Existing vascular stents are prone to vascular damage, platelet aggregation, and activation of coagulation factors after implantation, leading to serious complications such as in-stent rethrombosis and restenosis. There is a lack of materials with highly effective antithrombotic function.
An antithrombotic coating is formed on a substrate material. The coating contains polyphenol polymers, metal ions, and thrombin inhibitors. The polyphenols are selected from plant polyphenols, the metal ions are strontium ions, copper ions, or zinc ions, and the thrombin inhibitors are bivalirudin, hirudin, or dabigatran. The metal ion polyphenol coating is formed through a reaction, and the thrombin inhibitor is introduced to enhance the anticoagulant function.
It significantly reduces thrombus formation after vascular stent implantation, improves biocompatibility and antiplatelet aggregation ability, protects endothelial cells, and prevents the formation of acute thrombosis.
Smart Images

Figure CN118976162A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biological and medical materials, and in particular to an anti-thrombotic coating material and a preparation method and application thereof. Background Art
[0002] Cardiovascular disease remains the leading cause of death worldwide, with atherosclerosis having the greatest impact. The main manifestations of atherosclerosis are arterial remodeling, thickening of the intima-media membrane of the arterial wall, and formation of atherosclerotic plaques, which cause narrowing of the arterial lumen and ultimately lead to arterial occlusion, resulting in ischemia or even necrosis of the target organ. The existing reliable method of intravascular treatment is to physically expand the target blood vessel through a stent, so as to open the occluded blood vessel, increase blood supply to the target organ, and promote the recovery of target organ function. Vascular stents are currently the mainstream method for treating atherosclerosis.
[0003] However, implantation of vascular stents will cause vascular damage, leading to endothelial shedding, and further causing a series of pathophysiological reactions such as platelet aggregation, inflammatory response, and activation of coagulation factors, which will cause serious postoperative acute complications such as stent re-thrombosis and restenosis.
[0004] Therefore, there is an urgent need to develop materials with highly effective anti-thrombotic functions to significantly reduce complications after vascular stent implantation.
[0005] In view of this, the present invention is proposed. Summary of the invention
[0006] The purpose of the present invention is to provide an anti-thrombotic coating material and a preparation method and application thereof, aiming to prepare a material with high-efficiency anti-thrombotic function.
[0007] The present invention is achieved in that:
[0008] In a first aspect, the present invention provides an anti-thrombotic coating material, comprising a substrate material and an anti-thrombotic coating attached to the substrate material, wherein the anti-thrombotic coating contains a polyphenol polymer, and the polyphenol polymer is combined with metal ions and a thrombin inhibitor;
[0009] The polyphenols used to form the polyphenol polymers are plant polyphenols containing a polyhydroxyphenol chemical structure;
[0010] The metal ion is selected from at least one of strontium ion, copper ion and zinc ion;
[0011] The thrombin inhibitor is at least one selected from the group consisting of bivalirudin, hirudin, dabigatran and argatroban.
[0012] In an alternative embodiment, the metal ion is a strontium ion and the thrombin inhibitor is bivalirudin;
[0013] Preferably, in the anti-thrombotic coating, the mass fraction of the metal ions is 1%-40%, and the mass fraction of the thrombin inhibitor is 1%-50%.
[0014] In an optional embodiment, the plant polyphenol is selected from at least one of proanthocyanidins, brown algae polyphenols, quercetin, resveratrol and rosmarinic acid;
[0015] More preferably, the plant polyphenols are proanthocyanidins.
[0016] In an optional embodiment, the substrate material is selected from at least one of a metal-based biomaterial, an inorganic non-metal-based biomaterial, and a polymer-based biomaterial;
[0017] Preferably, the metal-based biomaterial includes stainless steel, iron and its alloys, magnesium and its alloys, titanium and its alloys, and cobalt-based alloys;
[0018] Inorganic non-metallic biomaterials include titanium dioxide, titanium oxide, titanium nitride, ceramics, silicon, silicon dioxide, silicon carbide, calcium phosphate silicon nitride, calcium phosphate, aluminosilicate, calcium aluminum system, bioglass, hydroxyapatite, carbon materials, diamond and diamond-like carbon;
[0019] Polymer-based biomaterials include polyester, polytetrafluoroethylene, polyurethane, polyoxymethylene, silicone rubber, polylactic acid, glycolide-lactide copolymer, polytrimethylene carbonate, and polycaprolactone.
[0020] In a second aspect, the present invention provides a method for preparing an anti-thrombotic coating material according to any one of the aforementioned embodiments, comprising: placing a substrate material in a mixed solution containing polyphenols and metal ions to react, thereby forming a metal ion polyphenol coating on the substrate material;
[0021] The substrate material having the metal ion polyphenol coating is placed in a thrombin inhibitor solution for reaction.
[0022] In an optional embodiment, the preparation process of the mixed solution includes: mixing and dissolving the polyphenol, the soluble metal salt and the solvent, and adjusting the pH value to 7-9;
[0023] Preferably, in the mixed solution, the concentrations of polyphenols and soluble metal salts are both 0.5 mg / mL-10 mg / mL; more preferably, in the mixed solution, the concentrations of polyphenols and soluble metal salts are both 0.5 mg / mL-3 mg / mL;
[0024] Preferably, the solvent is a buffer solution with a pH value of 8-8.5.
[0025] In an alternative embodiment, the soluble metal salt is selected from at least one of strontium chloride, strontium nitrate and strontium sulfate.
[0026] In an optional embodiment, the reaction temperature of the substrate material in the mixed solution is 20°C-37°C, and the reaction time is 12h-48h;
[0027] Preferably, the reaction temperature of the substrate material in the mixed solution is 25°C-37°C, and the reaction time is 12h-14h;
[0028] Preferably, after the reaction in the mixed solution is completed, the material is taken out for washing and drying.
[0029] In an optional embodiment, the concentration of thrombin inhibition in the thrombin inhibitor solution is 0.5 mg / mL-10 mg / mL;
[0030] Preferably, the reaction temperature in the thrombin inhibitor solution is 20° C.-37° C., and the reaction time is 12 h-24 h.
[0031] In a third aspect, the present invention provides use of any of the anti-thrombotic coating materials in the aforementioned embodiments or the anti-thrombotic coating material prepared by any of the preparation methods in the aforementioned embodiments in the preparation of implantable medical devices;
[0032] Preferably, the implanted medical device is selected from at least one of a vascular stent, a central venous catheter, a wound dressing and an artificial joint.
[0033] The present invention has the following beneficial effects: an anti-thrombotic coating containing polyphenol polymers, metal ions and thrombin inhibitors is formed on a substrate material, and metal-plant polyphenols are introduced on the surface of the substrate. Plant polyphenols have anti-platelet aggregation, strong antioxidant properties, antibacterial properties, good biocompatibility and biodegradability. Different metals can be added at the same time, so that the coating also has functions such as nerve repair and endothelial cell protection. Further, the thrombin inhibitor is introduced. The thrombin inhibitor has a stronger anti-thrombin activity, which can inhibit the binding of thrombin to its substrate plasma fibrinogen, and help prevent the formation of acute thrombus in the stent. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.
[0035] Figure 1 The scanning electron microscope results of the anti-platelet adhesion and activation experiments of Example 1, Comparative Example 1, Comparative Example 2, and Comparative Example 3 are shown;
[0036] Figure 2This is a graph showing the coagulation time (TT) test results of the surface coatings of Example 1 and Comparative Examples 1, 2, and 3. DETAILED DESCRIPTION
[0037] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.
[0038] An embodiment of the present invention provides a method for preparing an anti-thrombotic coating material, comprising the following steps:
[0039] S1. Preparation of mixed solution
[0040] A mixed solution containing polyphenols and metal ions is prepared for standby use. The metal ions are selected from at least one of strontium ions, copper ions and zinc ions. The metal ions can be any one or more of the above, preferably strontium ions. Strontium ions and plant polyphenols have better synergistic effects and can enhance the anti-thrombotic performance of the coating.
[0041] In actual operation, polyphenols, soluble metal salts and solvents are mixed and dissolved, and the pH value is adjusted to 7-9, such as 7.0, 7.5, 8.0, 8.5, 9.0, etc. Within this pH value range, the deposition efficiency can be further improved, and the deposition of polyphenols on the substrate can be promoted.
[0042] In some embodiments, the polyphenols may be plant polyphenols containing a polyhydroxyphenol chemical structure, which have anti-platelet aggregation, strong antioxidant, antibacterial, good biocompatibility and biodegradability, and are beneficial to improving the anti-thrombotic performance of the coating. The plant polyphenols are selected from at least one of proanthocyanidins, brown algae polyphenols, quercetin, resveratrol and rosmarinic acid, and the plant polyphenols may be any one or more of the above; preferably proanthocyanidins. By further optimizing the plant polyphenols, the anti-thrombotic performance of the coating can be further enhanced, which helps to prevent the formation of acute thrombosis in the stent.
[0043] In some embodiments, the soluble metal salt is selected from at least one of strontium chloride, strontium nitrate and strontium sulfate, and the soluble metal salt can be any one or more of the above. Introducing strontium ions can further improve the anti-thrombotic performance of the coating compared to copper ions or zinc ions.
[0044] In some embodiments, in the mixed solution, the concentrations of polyphenols and soluble metal salts are both 0.5 mg / mL-10 mg / mL, and the concentrations of plant polyphenol solutions and soluble metal salt solutions can be in a wide range, and both can form metal-phenol chelates. In a preferred embodiment, in the mixed solution, the concentrations of polyphenols and soluble metal salts are both 0.5 mg / mL-3 mg / mL. By further optimizing the concentration of the solution and the amount of the two main raw materials, the coating can further enhance its anti-platelet aggregation, anti-oxidation, antibacterial, neurorepair, anti-platelet and other effects.
[0045] Specifically, in the mixed solution, the concentrations of polyphenols and soluble metal salts may be the same or different, and may independently be 0.5 mg / mL, 1.0 mg / mL, 2.0 mg / mL, 3.0 mg / mL, 4.0 mg / mL, 5.0 mg / mL, 6.0 mg / mL, 7.0 mg / mL, 8.0 mg / mL, 9.0 mg / mL, 10.0 mg / mL, etc., or may be any value among the above adjacent values.
[0046] In some embodiments, the solvent can be a buffer solution with a pH value of 8-8.5. The specific type of the buffer solution is not limited. The "metal-phenol" forms a film on the substrate material in the buffer by utilizing the strong binding force of the ortho-phenol structure in the polyphenol compound to various substrate materials, and introduces metal ions through its chelating ability. The solvent can also be water. After dissolving the soluble metal salt and the plant polyphenol in water, the pH value is adjusted to meet the reaction requirements (such as 7-9) using sodium hydroxide solution to promote the deposition of the plant polyphenol.
[0047] S2. Formation of metal ion polyphenol coating
[0048] The base material is placed in a mixed solution containing polyphenols and metal ions to react, forming a metal ion polyphenol coating on the base material. Plant polyphenols have anti-platelet aggregation, strong antioxidant, antibacterial properties, good biocompatibility and biodegradability. The coordination of different metal ions enables the coating to have multiple biological functions such as nerve repair and protection of endothelial cells.
[0049] The type of substrate material is not limited, and a suitable substrate material can be selected according to the application scenario of the coating. The substrate material is selected from at least one of metal-based biomaterials, inorganic non-metal-based biomaterials, and polymer-based biomaterials. The substrate material can be any one of the above, or a composite material formed by several of them.
[0050] Furthermore, the metal-based biomaterials include stainless steel, iron and its alloys, magnesium and its alloys, titanium and its alloys, and cobalt-based alloys, and the substrate material may be any one or more of the above metal-based biomaterials.
[0051] Furthermore, inorganic non-metal-based biomaterials include titanium dioxide, titanium oxide, titanium nitride, ceramics, silicon, silicon dioxide, silicon carbide, calcium phosphate silicon nitride, calcium phosphate, aluminosilicate, calcium aluminum system, bioglass, hydroxyapatite, carbon material, diamond and diamond-like carbon, and the substrate material can be any one or more of the above inorganic non-metal-based biomaterials.
[0052] Furthermore, the polymer-based biomaterials include polyester, polytetrafluoroethylene, polyurethane, polyoxymethylene, silicone rubber, polylactic acid, glycolide-lactide copolymer, polytrimethylene carbonate and polycaprolactone, and the base material can be any one or more of the above polymer-based biomaterials.
[0053] In some embodiments, the reaction temperature of the substrate material in the mixed solution is 20°C-37°C, and the reaction time is 12h-48h. The reaction temperature and time can be selected in a wide range. In a preferred embodiment, the reaction temperature is 25°C-37°C, and the reaction time is 12h-14h. By further optimizing the reaction temperature and time, a coating is quickly formed on the surface of the substrate to ensure the introduction of the metal-phenol chelate group.
[0054] Specifically, the reaction temperature can be 20°C, 25°C, 30°C, 35°C, 37°C, etc., or any value between the above adjacent temperature values; the reaction time can be 12h, 14h, 18h, 20h, 24h, 28h, 30h, 36h, 40h, 48h, etc., or any value between the above adjacent time values. After the reaction in the mixed solution is completed, the material is taken out for washing and drying, and the washing can be multiple water washings, and the unreacted substances remaining on the surface can be removed by washing.
[0055] In some embodiments, before the substrate material is placed in the mixed solution, the substrate material is first thoroughly cleaned and dried to enhance the bonding strength of the coating.
[0056] S3. Introduction of thrombin inhibitors
[0057] The base material with the metal ion polyphenol coating is placed in a thrombin inhibitor solution for reaction, and the thrombin inhibitor is introduced into the coating, so that the coating has a stronger antithrombin activity, which can inhibit the binding of thrombin to its substrate plasma fibrinogen and help prevent the formation of acute thrombus in the stent.
[0058] In some embodiments, the thrombin inhibitor is selected from at least one of bivalirudin, hirudin, dabigatran and argatroban, and the thrombin inhibitor can be any one or more of the above. In a preferred embodiment, the thrombin inhibitor is bivalirudin, and the introduction of bivalirudin into the metal ion polyphenol coating can further inhibit the binding of thrombin to its substrate plasma fibrinogen, which helps to prevent the formation of acute thrombosis in the stent.
[0059] In some embodiments, the concentration of thrombin inhibition in the thrombin inhibitor solution is 0.5 mg / mL-10 mg / mL, such as 0.5 mg / mL, 1.0 mg / mL, 2.0 mg / mL, 3.0 mg / mL, 4.0 mg / mL, 5.0 mg / mL, 6.0 mg / mL, 7.0 mg / mL, 8.0 mg / mL, 9.0 mg / mL, 10.0 mg / mL, etc., or any value in the above adjacent values. By further optimizing the concentration of thrombin inhibitor, the anti-coagulation ability of the coating can be further improved, which helps to prevent the formation of acute thrombus.
[0060] Further, the reaction temperature in the thrombin inhibitor solution is 20°C-37°C, and the reaction time is 12h-24h. The reaction temperature and time can be selected within a wide range. In a preferred embodiment, the reaction temperature is 25-37°C, and the reaction time is 12-14h. By further optimizing the reaction temperature and time, the introduction of a thrombin inhibitor with excellent anticoagulant activity is ensured.
[0061] Specifically, the reaction temperature can be 20°C, 25°C, 30°C, 35°C, 37°C, etc., or any value between the above adjacent temperature values; the reaction time can be 12h, 14h, 18h, 20h, 24h, etc., or any value between the above adjacent time values. After the reaction is completed, the material is fully rinsed with distilled water and dried.
[0062] The embodiment of the present invention also provides an anti-thrombotic coating material, comprising a base material and an anti-thrombotic coating attached to the base material, wherein the anti-thrombotic coating contains a polyphenol polymer, and the polyphenol polymer is combined with metal ions and a thrombin inhibitor. The polyphenol used to form the polyphenol polymer is a plant polyphenol containing a polyhydroxyphenol chemical structure.
[0063] It should be noted that plant polyphenols have anti-platelet aggregation, strong antioxidant, antibacterial properties, good biocompatibility and biodegradability, and can be grafted with different metals, so that the coating has multiple biological functions such as nerve repair and endothelial cell protection. In addition, antithrombin inhibitors have excellent anticoagulant function and can effectively prevent acute thrombosis. This material has broad application prospects.
[0064] Further, the metal ion is selected from at least one of strontium ion, copper ion and zinc ion, and the metal ion can be any one or more of the above, preferably strontium ion. The thrombin inhibitor is selected from at least one of bivalirudin, hirudin, dabigatran and argatroban, and the thrombin inhibitor can be any one or more of the above, preferably bivalirudin.
[0065] Furthermore, in the anti-thrombotic coating, the mass fraction of metal ions is 1%-40% (such as 1%, 5%, 10%, 20%, 30%, 40%, etc.), and the mass fraction of thrombin inhibitors is 1%-50% (such as 1%, 5%, 10%, 20%, 30%, 40%, 50%, etc.).
[0066] The anti-thrombotic coating material provided in the embodiment of the present invention can be used in the preparation of implantable medical devices, and can be used to prepare the surface of implantable medical devices to enhance the anti-thrombotic performance of implantable medical devices.
[0067] Furthermore, the implanted medical device is selected from at least one of a vascular stent, a central venous catheter, a wound dressing and an artificial joint, and the implanted medical device may be any one or more of the above.
[0068] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.
[0069] Example 1
[0070] This embodiment provides a method for preparing an anti-thrombotic coating material, comprising the following steps:
[0071] (1) Thoroughly clean the 316L SS substrate material to be modified and dry it for later use.
[0072] (2) After dissolving proanthocyanidins and strontium chloride (SrCl2) in distilled water, the pH value was adjusted to 8.5 to obtain a mixed solution. In the mixed solution, the concentration of proanthocyanidins was 2.5 mg / mL and the concentration of strontium chloride was 2.5 mg / mL. The substrate material was placed in the mixed solution and reacted at 37°C for 12 hours.
[0073] (3) For the sample obtained in step (2), use dedistilled water for ultrasonic cleaning for 20 seconds, then use dedistilled water to clean it three times and dry it.
[0074] (4) The sample obtained in step (3) was immersed in a 1 mg / mL bivalirudin solution (the solvent was distilled water, the same below) and reacted at 25° C. for 14 h.
[0075] (5) For the sample obtained in step (4), use distilled water to wash three times, and then dry to obtain the target sample.
[0076] Example 2
[0077] This embodiment provides a method for preparing an anti-thrombotic coating material, comprising the following steps:
[0078] (1) Thoroughly clean the 316L SS substrate material to be modified and dry it for later use.
[0079] (2) Dissolve brown algae polyphenols and strontium chloride (SrCl2) in distilled water and adjust the pH value to 8.5 to obtain a mixed solution. In the mixed solution, the concentration of brown algae polyphenols is 2.5 mg / mL and the concentration of strontium chloride is 2 mg / mL. Place the substrate in the mixed solution and react at 37°C for 12 hours.
[0080] (3) For the sample obtained in step (2), use dedistilled water for ultrasonic cleaning for 20 seconds, then use dedistilled water to clean it three times and dry it.
[0081] (4) The sample obtained in step (3) was immersed in a 1 mg / mL bivalirudin solution and reacted at 25° C. for 14 h.
[0082] (5) For the sample obtained in step (4), use distilled water to wash three times, and then dry to obtain the target sample.
[0083] Example 3
[0084] This embodiment provides a method for preparing an anti-thrombotic coating material, comprising the following steps:
[0085] (1) Thoroughly clean the 316L SS substrate material to be modified and dry it for later use.
[0086] (2) After dissolving quercetin and strontium chloride (SrCl2) in distilled water, the pH value was adjusted to 8.5 to obtain a mixed solution. In the mixed solution, the concentration of quercetin was 2.5 mg / mL and the concentration of strontium chloride was 2.5 mg / mL. The substrate material was placed in the mixed solution and reacted at 37°C for 12 hours.
[0087] (3) For the sample obtained in step (2), use dedistilled water for ultrasonic cleaning for 20 seconds, then use dedistilled water to clean it three times and dry it.
[0088] (4) The sample obtained in step (3) was immersed in a 1 mg / mL bivalirudin solution and reacted at 25° C. for 14 h.
[0089] (5) For the sample obtained in step (4), use distilled water to wash three times, and then dry to obtain the target sample.
[0090] Example 4
[0091] The only difference from Example 1 is that the polyphenols in step (2) are replaced by an equal amount of brown algae polyphenols.
[0092] Example 5
[0093] The only difference from Example 1 is that in step (2), the polyphenols are replaced by an equal amount of rosmarinic acid.
[0094] Example 6
[0095] The only difference from Example 1 is that in step (2), strontium chloride is replaced by an equal amount of cupric chloride.
[0096] Example 7
[0097] The only difference from Example 1 is that in step (2), strontium chloride is replaced by an equal amount of zinc chloride.
[0098] Comparative Example 1
[0099] This comparative example provides a method for preparing an anti-thrombotic coating material, which differs from Example 1 only in that metal ions are not introduced in step (2). The specific steps are as follows:
[0100] (1) Thoroughly clean the 316L SS substrate material to be modified and dry it for later use.
[0101] (2) After the proanthocyanidins were dissolved, the pH value was adjusted to 8.5 and the proanthocyanidin concentration was 2.5 mg / mL. The base material was placed therein and reacted at 37° C. for 12 hours.
[0102] (3) For the sample obtained in step (2), use dedistilled water for ultrasonic cleaning for 20 seconds, then use dedistilled water to clean it three times and dry it.
[0103] (4) The sample obtained in step (3) was immersed in 1 mg / mL of bivalirudin and reacted at 25° C. for 14 h.
[0104] (5) For the sample obtained in step (4), use distilled water to wash three times, and then dry to obtain the target sample.
[0105] Comparative Example 2
[0106] This comparative example provides a method for preparing an anti-thrombotic coating material, which differs from Example 1 only in that the metal strontium ion in step (2) is replaced by an equal amount of sodium ions. The specific steps are as follows:
[0107] (1) Thoroughly clean the 316L SS substrate material to be modified and dry it for later use.
[0108] (2) After dissolving proanthocyanidins and sodium chloride (NaCl) in distilled water, the pH value was adjusted to 8.5, the proanthocyanidin concentration was 2.5 mg / mL, and the sodium chloride concentration was 2.5 mg / mL, and the mixture was reacted at 37°C for 12 hours.
[0109] (3) For the sample obtained in step (2), use dedistilled water for ultrasonic cleaning for 20 seconds, then use dedistilled water to clean it three times and dry it.
[0110] (4) The sample obtained in step (3) was immersed in a 1 mg / mL bivalirudin solution and reacted at 25° C. for 14 h.
[0111] (5) For the sample obtained in step (4), use distilled water to wash three times, and then dry to obtain the target sample.
[0112] Comparative Example 3
[0113] This comparative example provides a method for preparing an anti-thrombotic coating material, which differs from Example 1 only in that the polyphenol in step (2) is replaced by an equal amount of tannic acid. The specific steps are as follows:
[0114] (1) Thoroughly clean the 316L SS substrate material to be modified and dry it for later use.
[0115] (2) Dissolve tannic acid and strontium chloride (SrCl2) in distilled water and adjust the pH value to 8.5 to obtain a mixed solution. In the mixed solution, the concentration of tannic acid is 2.5 mg / mL and the concentration of strontium chloride is 2.5 mg / mL. Place the substrate in the mixed solution and react at 37°C for 12 hours.
[0116] (3) For the sample obtained in step (2), use dedistilled water for ultrasonic cleaning for 20 seconds, then use dedistilled water to clean it three times and dry it.
[0117] (4) The sample obtained in step (3) was immersed in a 1 mg / mL bivalirudin solution and reacted at 25° C. for 14 h.
[0118] (5) For the sample obtained in step (4), use distilled water to wash three times, and then dry to obtain the target sample.
[0119] Comparative Example 4
[0120] The only difference from Example 1 is that in step (4), the bivalirudin solution is replaced by a hirudin solution of equal concentration.
[0121] Test Example 1
[0122] The materials obtained in Example 1, Comparative Example 1, Comparative Example 2, Comparative Example 3 and Comparative Example 4 were subjected to anti-platelet adhesion and activation experiments. The scanning electron microscope photos are shown in FIG. Figure 1 shown.
[0123] Test method: fresh rich board pulp was dripped on the surface of the materials prepared in Example 1, Comparative Example 1, Comparative Example 2, Comparative Example 3 and Comparative Example 4, incubated at 37°C for 30 minutes, washed with saline for 3 times, fixed with 2.5% glutaraldehyde for 12 hours, washed with saline for another 3 times, and then dehydrated with 50%, 70%, 90%, and 100% anhydrous ethanol at intervals of 1 hour, respectively, naturally air-dried, and further dried in a drying oven, and photographed with a scanning electron microscope.
[0124] from Figure 1 It can be seen that the number of platelets adhered and the degree of activation on the surface of Example 1 are significantly less than those in Comparative Example 1, Comparative Example 2, Comparative Example 3 and Comparative Example 4, showing excellent anti-platelet adhesion and activation functions, indicating that Example 1 has better blood compatibility.
[0125] Test Example 2
[0126] The coatings provided in Example 1, Comparative Example 1, Comparative Example 2, Comparative Example 3 and Comparative Example 4 were compared using a thrombin time experiment.
[0127] The experimental process is as follows: (1) Fresh whole blood was collected from adult New Zealand white rabbits, and all blood samples used 3.2% sodium citrate as an anticoagulant (volume ratio of 9:1). Centrifuge at 3000rpm for 15 minutes and collect the plate-poor plasma (PPP). (2) Add 250μL of fresh PPP to the surface of each sample and incubate at 37°C for 30 minutes. (3) Add the volume of buffer indicated on the bottle label to each bottle of TT reagent, let stand for 5 to 10 minutes, shake gently to dissolve, and place it at 25°C for preheating before use; (4) Take 200μL of the plasma to be tested after preheating at 37°C for 30 minutes, add 200μL of TT reagent, and record the coagulation time.
[0128] The results are as follows Figure 2 As shown, it can be obtained from Figure 2 It can be seen that Example 1 can prolong the TT time more significantly than Comparative Example 1, Comparative Example 2, Comparative Example 3 and Comparative Example 4, indicating that the coating prepared by the present invention has excellent anti-coagulation performance.
[0129] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. An anti-thrombotic coating material, characterized in that: It comprises a base material and an anti-thrombotic coating attached to the base material, wherein the anti-thrombotic coating contains a polyphenol polymer, and the polyphenol polymer is combined with metal ions and a thrombin inhibitor; The polyphenols used to form the polyphenol polymer are plant polyphenols containing a polyhydroxyphenol chemical structure; The metal ion is selected from at least one of strontium ion, copper ion and zinc ion; The thrombin inhibitor is at least one selected from the group consisting of bivalirudin, hirudin, dabigatran and argatroban.
2. The anti-thrombotic coating material according to claim 1, characterized in that: The metal ion is a strontium ion, and the thrombin inhibitor is bivalirudin; Preferably, in the anti-thrombotic coating, the mass fraction of the metal ions is 1%-40%, and the mass fraction of the thrombin inhibitor is 1%-50%.
3. The anti-thrombotic coating material according to claim 1, characterized in that: The plant polyphenol is selected from at least one of proanthocyanidins, brown algae polyphenols, quercetin, resveratrol and rosmarinic acid; Preferably, the plant polyphenols are proanthocyanidins.
4. The anti-thrombotic coating material according to any one of claims 1 to 3, characterized in that: The substrate material is selected from at least one of metal-based biomaterials, inorganic non-metal-based biomaterials and polymer-based biomaterials; Preferably, the metal-based biomaterial includes stainless steel, iron and its alloys, magnesium and its alloys, titanium and its alloys, and cobalt-based alloys; The inorganic non-metallic biomaterials include titanium dioxide, titanium oxide, titanium nitride, ceramics, silicon, silicon dioxide, silicon carbide, calcium phosphate silicon nitride, calcium phosphate, aluminosilicate, calcium aluminum system, bioglass, hydroxyapatite, carbon material, diamond and diamond-like carbon; The polymer-based biomaterials include polyester, polytetrafluoroethylene, polyurethane, polyoxymethylene, silicone rubber, polylactic acid, glycolide-lactide copolymer, polytrimethylene carbonate and polycaprolactone.
5. A method for preparing the anti-thrombotic coating material according to any one of claims 1 to 4, characterized in that: include: placing the substrate material in a mixed solution containing polyphenols and the metal ions to react, thereby forming a metal ion polyphenol coating on the substrate material; The base material having the metal ion polyphenol coating is placed in a thrombin inhibitor solution for reaction.
6. The preparation method according to claim 5, characterized in that: The preparation process of the mixed solution includes: mixing and dissolving the polyphenol, soluble metal salt and solvent, and adjusting the pH value to 7-9; Preferably, in the mixed solution, the concentrations of polyphenols and soluble metal salts are both 0.5 mg / mL-10 mg / mL; more preferably, in the mixed solution, the concentrations of polyphenols and soluble metal salts are both 0.5 mg / mL-3 mg / mL; Preferably, the solvent is a buffer solution with a pH value of 8-8.
5.
7. The preparation method according to claim 6, characterized in that: The soluble metal salt is selected from at least one of strontium chloride, strontium nitrate and strontium sulfate.
8. The preparation method according to claim 5 or 6, characterized in that: The reaction temperature of the substrate material in the mixed solution is 20°C-37°C, and the reaction time is 12h-48h; Preferably, the reaction temperature of the substrate material in the mixed solution is 25°C-37°C, and the reaction time is 12h-14h; Preferably, after the reaction in the mixed solution is completed, the material is taken out for washing and drying.
9. The preparation method according to claim 5, characterized in that: The concentration of thrombin inhibition in the thrombin inhibitor solution is 0.5 mg / mL-10 mg / mL; Preferably, the reaction temperature in the thrombin inhibitor solution is 20° C.-37° C., and the reaction time is 12 h-24 h.
10. Use of the anti-thrombotic coating material according to any one of claims 1 to 4 or the anti-thrombotic coating material prepared by the preparation method according to any one of claims 5 to 9 in the preparation of implantable medical devices; Preferably, the implanted medical device is selected from at least one of a vascular stent, a central venous catheter, a wound dressing and an artificial joint.
